These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2464903)

  • 21. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
    von Holst H; Lindquist C; Sedvall G
    Acta Neurochir (Wien); 1985; 77(3-4):146-51. PubMed ID: 2416192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report.
    Bryer JB; Starkstein SE; Votypka V; Parikh RM; Price TR; Robinson RG
    J Neuropsychiatry Clin Neurosci; 1992; 4(4):440-2. PubMed ID: 1384852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bromocriptine treatment of depressive disorders. Clinical and biochemical effects.
    Nordin C; Siwers B; Bertilsson L
    Acta Psychiatr Scand; 1981 Jul; 64(1):25-33. PubMed ID: 6172006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoamine metabolites in cerebrospinal fluid of depressive subgroups.
    Rosenthal NE; Davenport Y; Cowdry RW; Webster MH; Goodwin FK
    Psychiatry Res; 1980 Mar; 2(1):113-9. PubMed ID: 6158064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between CSF HVA/5-HIAA ratio and suicide intent in suicide attempters.
    Jokinen J; Nordström AL; Nordström P
    Arch Suicide Res; 2007; 11(2):187-92. PubMed ID: 17453696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder.
    Yoon HS; Hattori K; Ogawa S; Sasayama D; Ota M; Teraishi T; Kunugi H
    J Clin Psychiatry; 2017; 78(8):e947-e956. PubMed ID: 28749090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity.
    Sedvall G; Fyrö B; Gullberg B; Nybäck H; Wiesel FA; Wode-Helgodt B
    Br J Psychiatry; 1980 Apr; 136():366-74. PubMed ID: 6155965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder.
    Mårtensson B; Wägner A; Beck O; Brodin K; Montero D; Asberg M
    Acta Psychiatr Scand; 1991 Feb; 83(2):125-33. PubMed ID: 1708190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid.
    Blennow K; Wallin A; Gottfries CG; Månsson JE; Svennerholm L
    J Neural Transm Park Dis Dement Sect; 1993; 5(1):5-15. PubMed ID: 7679905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients.
    Widerlöv E; Bissette G; Nemeroff CB
    J Affect Disord; 1988; 14(2):99-107. PubMed ID: 2452842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
    Hsiao JK; Colison J; Bartko JJ; Doran AR; Konicki PE; Potter WZ; Pickar D
    Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gradients of CSF monoamine metabolites: a comparison between male and female volunteers.
    Nordin C; Eklundh T; Fernström V; Swedin A; Zachau AC
    J Psychiatr Res; 1995; 29(2):133-40. PubMed ID: 7545235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment.
    Härnryd C; Bjerkenstedt L; Grimm VE; Sedvall G
    Psychopharmacology (Berl); 1979 Aug; 64(2):131-4. PubMed ID: 115032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
    Ogawa S; Tsuchimine S; Kunugi H
    J Psychiatr Res; 2018 Oct; 105():137-146. PubMed ID: 30219563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid.
    Rogers J; Martin LJ; Comuzzie AG; Mann JJ; Manuck SB; Leland M; Kaplan JR
    Biol Psychiatry; 2004 Apr; 55(7):739-44. PubMed ID: 15039003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine.
    Asberg M; Ringberger VA; Sjöqvist F; Thorén P; Träskman L; Tuck JR
    Clin Pharmacol Ther; 1977 Feb; 21(2):201-7. PubMed ID: 13959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls.
    Engström G; Alling C; Blennow K; Regnéll G; Träskman-Bendz L
    Eur Neuropsychopharmacol; 1999 Sep; 9(5):399-405. PubMed ID: 10523046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoamine neurotransmitter interactions and the prediction of antidepressant response.
    Hsiao JK; Agren H; Bartko JJ; Rudorfer MV; Linnoila M; Potter WZ
    Arch Gen Psychiatry; 1987 Dec; 44(12):1078-83. PubMed ID: 2446588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
    Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients.
    Sedvall GC; Wode-Helgodt B
    Arch Gen Psychiatry; 1980 Oct; 37(10):1113-6. PubMed ID: 6158928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.